ADA 2010: Gut bacteria can affect obesity
June 30th 2010Obesity and leanness are more than calories in and energy out. The amount of adipose tissue an individual carries is also a function of his or her intestinal microbiota. Research in mice and humans suggests that individuals with more Firmicutes and fewer Bacteroidetes tend to be more obese.
ADA 2010: Will DPP-4 inhibitors replace sulfonylureas? Debaters make their case
June 30th 2010Although their ability to control glycemia is essentially the same, do other merits of dipeptidyl peptidase 4 (DPP-4) inhibitors favor their replacing sulfonylureas in the treatment armamentarium for type 2 diabetes? Michael Nauck, MD, and David Matthews, FRCP, were on opposing sides of this issue.
ADA 2010: Glycated hemoglobin levels correlate strongly to future diabetes, cardiovascular risk
June 29th 2010An ancillary study to the ARIC (Atherosclerosis Risk in Communities) study supports the most recent (2010) ADA risk categories of glycated hemoglobin in identifying future risk of developing diabetes and macrovascular and microvascular disease.
ADA 2010: Liraglutide more successful than sitagliptin in achieving glycemic target
June 28th 2010Liraglutide is more successful in reducing glycated hemoglobin levels to 7% or less regardless of baseline glycated hemoglobin level compared with sitagliptin in adults with type 2 diabetes, said Melanie Davies, MD, MB ChB, professor of diabetes medicine, University of Leicester, United Kingdom.
Overuse of antibiotics spurs vicious cycle
June 23rd 2010Patients whose doctors over-prescribe antibiotics may develop drug resistance that can last up to a year, putting them and others at risk when more serious treatment is needed, according to a study published in May in the British Medical Journal.
Community pharmacists to gather for annual NCPA convention
June 23rd 2010The National Community Pharmacists Association (NCPA) will present the latest in pharmacy education, case studies, and real-world, business-oriented information for the independent community-pharmacy industry at its 112th Annual Convention and Trade Exposition taking place at the Pennsylvania Convention Center in Philadelphia Oct. 23 to 27.
Counterfeit Tamiflu sold on Internet puts consumers at risk
June 23rd 2010FDA notified consumers and healthcare professionals that a product represented as "Generic Tamiflu" being sold on the Internet does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.